Status:
COMPLETED
Utility of Breath-holding Test in Systemic Sclerosis
Lead Sponsor:
Seoul National University Hospital
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study aims to evaluate the utility of breath-holding test as a marker of pulmonary disease severity in patients with systemic sclerosis.
Detailed Description
Systemic sclerosis (SSc) is a chronic autoimmune disease of unknown etiology with high morbidity and mortality. SSc manifests by fibrosis of skin and internal organs. Although the underlying mechanism...
Eligibility Criteria
Inclusion
- A diagnosis of systemic sclerosis according to 2013 ACR/EULAR criteria
- Must understand and voluntarily sign an informed consent form including writing consent for data protection
Exclusion
- The resting oxygen saturation by pulse oximetry \< 90% in room air
- Unstable angina or myocardial infarction during the previous month
- Patients considered unable to the breath-holding test or 6 minute walk test
Key Trial Info
Start Date :
August 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04484948
Start Date
August 12 2020
End Date
May 31 2023
Last Update
June 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080